ALS Center
  • Home
  • About ALS
    • About ALS
    • ALS Treatment Options
    • ALS Symptom Management
    • Frequently Asked Questions
    • Living with ALS
    • Everyday Life with ALS
  • Patient Care
    • The Clinic Experience
    • Multi Disciplinary Care
  • Research
    • Active Studies
    • Research Highlights
    • Research Teams
    • Other Resources
  • About Us
    • Our History
    • Our Teams
    • Contact
  • News & Events
  • Donate
Select Page
Biomarkers for ALS Therapy Development

Biomarkers for ALS Therapy Development

by Michael Benatar | Sep 1, 2020 | Events, Press Releases

  Dr. Michael Benatar, Executive Director of the University of Miami’s ALS Center, gave a webinar about Biomarkers at the 2020 ALSA Advocacy Day. He discussed the importance of biomarkers and how they are essential to developing therapies for patients with...
University of Miami ALS Center to Receive Critical Funding from the State of Florida

University of Miami ALS Center to Receive Critical Funding from the State of Florida

by Michael Benatar | Jul 23, 2020 | Press Releases, Research Highlights

September 25, 2020 (University Of Miami press release) On June 29, 2020, Governor Ron DeSantis approved $800,000 in funding for the Bitner Plante ALS Initiative of Florida in the 2020-2021 budget. This Initiative provides support for ALS patients receiving treatment...
Research survey for rare disease patients and their families about impacts of COVID-19

Research survey for rare disease patients and their families about impacts of COVID-19

by Michael Benatar | May 19, 2020 | Press Releases

How is the novel coronavirus pandemic impacting people with rare diseases and their families? Complete the 20-minute research survey from home or learn more at this link.
UM Researchers’ Validation of ALS Biomarker Could Accelerate Development of New Therapies

UM Researchers’ Validation of ALS Biomarker Could Accelerate Development of New Therapies

by Michael Benatar | May 19, 2020 | Press Releases

May 8, 2020 (University Of Miami press release) “Therapy development for ALS is challenging for many reasons,” said Michael Benatar, M.D., Ph.D., professor of neurology, the Walter Bradley Chair in ALS Research, and executive director of the ALS Center at the...
CReATe Consortium Aims for ALS Breakthroughs with NIH Renewal Grant

CReATe Consortium Aims for ALS Breakthroughs with NIH Renewal Grant

by admin | Oct 25, 2019 | Press Releases

October 4, 2019 (University of Miami press release) An international research consortium led by investigators at the University of Miami Miller School of Medicine has made significant progress in understanding amyotrophic lateral sclerosis (ALS) and related diseases...
Next Entries »

Recent Posts

  • Landmark Study Identifies Novel Pre-Symptomatic Biomarkers and Accelerates Progress Towards ALS Prevention
  • Webinar: Update on the ATLAS Trial for Asymptomatic SOD1 Gene Carriers
  • Miami Marlins Game
  • Feature: UHealth’s Qalsody Clinic Provides Cutting-Edge Care for ALS Patients
  • The New York Times Feature: In a Milestone for A.L.S., a Treatment Helps Some Patients Improve
  • Facebook
  • X
  • Instagram
  • RSS

Designed by Elegant Themes | Powered by WordPress